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INTRODUCTION
The Patient Protection and Affordable Care Act (ACA) prioritizes the delivery of high quality healthcare, encourages healthcare systems to track and report quality of care (QOC) measures, and allows for healthcare funders to link provider payments to these measures 1 . QOC provided by a healthcare delivery system or individual provider is typically measured by disease-specific care process measures, called quality indicators (QIs). These QIs assess whether an individual patient receives a particular healthcare procedure during a specified timeframe, if the patient is eligible to receive that care. QIs are used to inform healthcare providers, systems administrators, funders, and the general population of the overall QOC delivered by a healthcare system or individual providers. Summary measures of individual QIs are increasingly used to assess overall care quality 2, 3 . HIV QIs are well-established, with growing consensus on a body of QIs endorsed by the US Health Resources Services Administration (HRSA) HIV/AIDS Bureau, the Veterans Health Administration (VHA), the Institute of Medicine (IOM) and the National Quality Forum (NQF) 4, 5 .
As in most chronic illnesses, individual process measures are often selected based on clinical trials that demonstrate their association with favorable outcomes 6, 7 . The link between a group of disease-specific process measure QIs and outcomes has been difficult to demonstrate in clinical practice. The few chronic illnesses that have done so, including diabetes and acute myocardial infarction 8, 9 , have not focused on vulnerable populations such as patients with HIV infection or substance use. Little is known regarding the association between aggregate receipt of care process measures, as a whole, and outcomes such as mortality.
Survival rates have historically varied among HIV-infected patients. Combined antiretroviral treatment (cART) use has increased survival for some HIV-infected patients from a few years to decades 10, 11 . While historic gender and race/ethnicity gaps in life expectancy for HIV-infected patients have narrowed over the past decade, life expectancy has remained unchanged since Quality of HIV care is suboptimal for HIV-infected patients with substance use [14] [15] [16] [17] In a recent study of HIV-infected veterans, both recent unhealthy alcohol use and illicit drug use were inversely associated with the percentage of QIs received 16 . Whether decreased quality of HIV care is an independent predictor of decreased survival in HIV-infected patients with unhealthy alcohol or drug use is not known. Substance use may be an important confounder of an association between QOC and mortality.
We, therefore, chose to examine the association between QOC and mortality in a population of HIV-infected patients, where receipt of high QOC might have the potential to close deficits in disease outcomes. Our objective was to a) assess the association between quality of HIV care and mortality, and b) assess the potential for high quality care to close gaps in mortality for HIVinfected patients with past year unhealthy alcohol and/or illicit drug use. We hypothesized that a) receiving a greater number of eligible HIV QIs would be associated with improved mortality, and b) that mortality would be comparable for those who received the highest quality of HIV care, regardless of past year unhealthy alcohol or illicit drug use.
METHODS

Setting & Participants
We conducted a longitudinal survival analysis among HIV-infected patients enrolled in the Veterans Aging Cohort Study (VACS), an ongoing study that has been described previously 18, 19 . Briefly, VACS is a national cohort study of HIV-infected patients receiving care at 8 VHA Participants were excluded from the analysis if they died or were lost to follow-up in the 12 months following enrollment, since QOC was assessed during this timeframe.
Measures
The independent variable for the current study was quality of HIV care in the 12 months after enrollment. We measured 9 process QIs from therapeutic, monitoring, screening, and prevention domains ( Table 1) . QIs were only assessed if a patient was eligible to receive the indicated care process (e.g. the cART QI was only considered "met" if the participant's CD4 count nadir was < 350 cells/mL 3 , consistent with treatment guidelines during the study period).
All participants were eligible to receive at least five QIs and could receive as many as nine depending on eligibility. The QIs were originally developed through modified Delphi methods . For example, if six QIs were met for a person who was eligible to receive nine, that person received 66.6% (6/9 x 100) of the QIs for which he or she was eligible. We dichotomized the percent of quality of HIV care received as ≥ 80% of QIs vs. < 80% since mortality rates were comparable for those with 100% and ≥ 80% of QIs and generally declined thereafter (Supplemental Table 4 The primary outcome measure was overall mortality, assessed beginning 12 months after enrollment. Deaths were identified from four sources: 1) the Patient Treatment File, which records hospital deaths in the VA healthcare system, 2) the Beneficiary Identification Records Locating System, which tracks VA death benefits, 3) the Medicare Vital Status File, and 4) the Social Security National Death Index. Mortality was assessed through July 31, 2014, allowing for a follow up period of up to 11 years with a mean of 8.2 years (standard deviation = 3.2).
Other independent variables and covariates included self-reported unhealthy alcohol use and illicit drug use from a survey at the time of study enrollment. Unhealthy alcohol use, which includes at-risk drinking, alcohol abuse, and dependence in the past 12 months was defined by a three-item Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) score ≥ 4 25 26 .
The AUDIT-C is a universal, annual screening measure for patients in primary care clinics in the VHA. Illicit drug use was defined by any self-reported use of non-prescribed stimulants, opioids, or injection drugs in the past 12 months 27, 28 .
We also considered potential covariates that might influence mortality including gender, race/ethnicity, age, education level, homelessness, baseline CD4 count, suppression of HIV viral replication, cART, hepatitis C (HCV) status, and the VACS Index as a measure of overall health. The VACS Index is a predicator of mortality in HIV-infected patients, comprised of measures of age, CD4 count, HIV-1 RNA, hemoglobin, liver fibrosis (Fib-4), renal function (e-GFR), and HCV status 29, 30 .
Analysis
We report patient characteristics overall and by unhealthy alcohol use (yes/no) and illicit drug use (yes/no) using descriptive statistics. We compared continuous variables (age) using ttests and categorical variables using chi-square tests. Mortality rates in deaths per 100 personyears (PY) were calculated. We estimated associations between the dichotomous percent of QIs received (≥ 80% vs. < 80%) and overall mortality using Kaplan Meier survival analysis and univariate and multivariate Cox proportional hazards models. Analyses were stratified by past year unhealthy alcohol and illicit drug use to test the hypothesis that receiving higher quality of HIV care might narrow gaps in mortality observed for these patients. A priori covariates of age, gender, race/ethnicity, CD4<200 cells/µL, and site were assessed by adding each individually to the univariate models; if the model QI coefficient changed by more than 10% compared to the QI coefficient in the univariate model, the variable was included in the multivariate models. .
Only age met the criteria to be included in the multivariate models adjusted for demographic characteristics. A second set of multivariate models were run adjusting for the VACS Index. We tested the proportional hazards assumption using Schoenfeld and scaled Schoenfeld residuals and found that there was no violation of the global proportional hazards assumption. We conducted sensitivity analysis 1) limiting observation time to 2 years to explore the effect of healthy survivor bias and 2) stratifying by mutually exclusive categories of no unhealthy alcohol use or illicit drug use, unhealthy alcohol use only, illicit drug use only, and both unhealthy alcohol and illicit drug use, and 3) using alternative QOC thresholds of ≥ 50% and 100% of QIs received.
RESULTS
The majority of the 3,038 HIV-infected participants were male (97.5%), Black (66.8%), and had completed a high school education or GED (59.5%); mean age was 49.0 years (SD 8.8) ( Table 2) . At study enrollment, 83.9% were prescribed cART, 76.7% had a CD4 count ≥ 200 cells/mL 3 , and 55.6% had an undetectable HIV viral load. Substance use was prevalent, with 25.9% reporting unhealthy alcohol use, 28.4% reporting illicit drug use, and 11.2% reporting both unhealthy alcohol and illicit drug use in past year. Marijuana (27.6%) was the most frequently used drug, and 7.0% reported injection drug use. Participants with unhealthy alcohol use were more frequently male, younger, ever homeless, HCV-infected, and used drugs, and less frequently had a high school education, were receiving cART, or had an undetectable HIV viral load compared with those without unhealthy alcohol use. Participants with illicit drug use were more frequently ever homeless, HCV-infected, and less frequently had a high school Participants with current unhealthy alcohol and/or illicit drug use were less likely to receive ≥ 80% of eligible QIs compared to those without.
Participants were followed for a mean of 8.2 (SD 3.3) years. A total of 902 participants died (29.8%) over 24805 PY of follow-up. Mortality rates were higher for participants with past year illicit drug use than for those without and comparable for those with and without past year unhealthy alcohol use. Mortality rates were lowest for those who received ≥ 80% of HIV QIs for which they were eligible, regardless of substance use ( Table 2 ).
All participants who received ≥ 80% of eligible HIV experienced lower hazards of ageadjusted mortality (Table 3) . Overall, receiving ≥ 80% of eligible QIs was associated with a 25% decrease in mortality compared to receiving a lower percent of eligible QIs (age-adjusted hazards ratio 0.75, 95% CI 0.65, 0.86). Similar benefits were observed regardless of substance use. This association was attenuated in models adjusting for severity of illness using the VACS Index.
In survival analyses, overall survival was better for those who received ≥ 80% of HIV QIs ( Figure 1A) . This was true among those with and without unhealthy alcohol use and with and without illicit drug use (Figures 1B, 1C) .
Sensitivity analyses limiting follow up to two years, and using alternative QOC thresholds of ≥ 50% and 100% of QIs received yielded similar results. Stratifying by four mutually exclusive substance use categories (no unhealthy alcohol use or illicit drug use, unhealthy alcohol use only, illicit drug use only, and both unhealthy alcohol and illicit drug use) yielded point estimates similar in direction that did not achieve the threshold for statistical significance due to small sample sizes (Supplemental Table 5 ). The current study finds that HIV-infected patients who receive high QOC experience improved mortality. These findings support policies that promote monitoring and reporting of QIs, suggesting that high quality care provided by healthcare systems and providers may translate into decreased mortality for their patients. Improving QOC alone, however, may be insufficient for overcoming the contribution of underlying disease severity to mortality.
The current study provides an example of a chronic illness in which improvements in QIs are associated with improved mortality and requires replication in other chronic illnesses. Few other chronic illnesses have reported mortality associated with process measures 8, 9 . Fourteen diabetes QIs were examined in a registry of 10,058 diabetic patients receiving care in the Netherlands, only four of which were associated with a decrease in a composite outcome of cardiovascular event or death 9 . In a survey of cardiac care units, optimal management scores were associated with decreased 30-day mortality for patients admitted for acute myocardial The current study findings should be interpreted in the context of several potential limitations. First, our study population of HIV-infected patients was limited to predominantly male U.S. military veterans who received care in the VHA, an organization whose systematic strategies to improve the QOC over the past two decades may have biased our results toward the null hypotheses. [37] [38] [39] [40] Replicating the current study in other healthcare systems may find an even greater association between QOC and survival. Second, we were unable to measure some QIs due to limitations of medical record data collection and validation (e.g. high risk sexual behavior screening and retention in care). Inclusion of these QIs in electronic medical record collection would facilitate assessment of such QIs for both clinical and research purposes. Third, we were unable to account for QIs delivered by non-VA providers. This is unlikely to bias results of most QIs (e.g., most HIV-infected veterans fill prescription for cART at VA pharmacies), but may be important for QIs commonly delivered in non-VA settings (e.g., influenza vaccinations). Fourth, there is little empirical evidence to support the use of an 80% of QIs threshold. However, achieving at least 80% of QIs has strong face validity as a reflection of high quality care and is often used as a performance target for non-HIV care in healthcare systems. Finally, we could not determine whether the association between QOC and survival was due to direct effects of care processes on survival, or because these measures were proxies for unmeasured patient characteristic or aspect of care that influenced survival. 
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